Account
FIHL hands media mandate to Carat India
MUMBAI: Franchise India Holdings (FIHL) has roped in Carat India, the flagship media agency from Dentsu Aegis Network, as its media agency.
Carat won the mandate following a multi-agency pitch and will now handle the account from its Gurgaon office. The win comes on the back of Carat’s new business wins, including Zee OTT and Columbia Asia in the recent past.
Franchise India chairman Gaurav Marya says, “To us, Carat came across as an agency that focuses on finding communication solutions keeping the business challenges at the centre. We are delighted with this partnership and wish Carat all the best as we embark on an exciting journey together.”
Carat India CEO Rajni Menon adds, “We look forward to working with Franchise India in taking their business to gain strong hold on the relevant audience. With Dentsu Aegis Network’s integrated approach and capabilities of delivering end to end solutions, we are confident of enabling a strong connect with the digital consumers of India.”
FIHL has helped hundreds of investors in selecting the right franchise and, in turn, assisted numerous organisations in international and domestic franchise expansion.
Franchise India aims to spend its majority of investments on digital media. Carat will manage the media planning and buying for all the investments.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
